PAS
EXAS

Park Avenue Securities’s Exact Sciences EXAS Stock Holding History

Park Avenue Securities’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,377
Closed -$1.16M – 1578
2025
Q4 		$1.16M Sell
11,377
-7,492
-40% -$602K 0.01% 748
2025
Q3 		$1.03M Sell
18,869
-1,519
-7% -$75.9K 0.01% 866
2025
Q2 		$1.08M Sell
20,388
-4,947
-20% -$251K 0.01% 755
2025
Q1 		$1.1M Buy
25,335
+1,449
+6% +$73.4K 0.01% 589
2024
Q4 		$1.34M Sell
23,886
-1,431
-6% -$89.1K 0.01% 629
2024
Q3 		$1.73M Sell
25,317
-7,210
-22% -$407K 0.02% 477
2024
Q2 		$1.37M Buy
32,527
+4,127
+15% +$227K 0.02% 534
2024
Q1 		$1.96M Buy
28,400
+7,151
+34% +$452K 0.03% 420
2023
Q4 		$1.57M Sell
21,249
-2
-0% -$131 0.02% 448
2023
Q3 		$1.45M Sell
21,251
-3,015
-12% -$256K 0.02% 430
2023
Q2 		$2.28M Sell
24,266
-1,480
-6% -$115K 0.04% 292
2023
Q1 		$1.75M Sell
25,746
-3,722
-13% -$239K 0.03% 321
2022
Q4 		$1.46M Buy
29,468
+3,821
+15% +$156K 0.03% 383
2022
Q3 		$833K Sell
25,647
-2,051
-7% -$84.6K 0.02% 529
2022
Q2 		$1.09M Buy
27,698
+2,244
+9% +$120K 0.02% 426
2022
Q1 		$1.78M Buy
25,454
+7,081
+39% +$518K 0.03% 310
2021
Q4 		$1.43M Buy
18,373
+1,823
+11% +$161K 0.03% 348
2021
Q3 		$1.58M Buy
16,550
+1,752
+12% +$185K 0.03% 288
2021
Q2 		$1.84M Buy
14,798
+3,144
+27% +$375K 0.04% 242
2021
Q1 		$1.54M Buy
11,654
+5,213
+81% +$714K 0.04% 244
2020
Q4 		$853K Buy
6,441
+3,832
+147% +$463K 0.02% 328
2020
Q3 		$266K Buy
+2,609
New +$225K 0.01% 619

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Park Avenue Securities's EXAS Position: Q1 2026 in Review

Park Avenue Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,377 shares — an estimated $1.16M sold.

Park Avenue Securities first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $2.28M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Park Avenue Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Park Avenue Securities sold 11,377 Exact Sciences shares in Q1 2026, an estimated $1.16M.
  • Park Avenue Securities first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • Park Avenue Securities's Exact Sciences position peaked at $2.28M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Park Avenue Securities's 13F filing for Q1 2026, filed 7 Apr 2026.